YB-840

N/A

Report date: 2026/01/05 15:58:12

Base Information

Drug NameYB-840

Drug Alias NameYB-840YB840

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionNeuronal pentraxin receptor inhibitors

TargetsNeuronal pentraxin receptor

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesYmmunobio AG

China Registration ClassN/A

Develop Information

Active CompaniesYmmunobio AG

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A